Faeth Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Faeth Therapeutics, Inc. (FTH) reported Increase (Decrease) in Prepaid Expense of -$10.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-04
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $384.00K.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$10.74M, a 2552.97% decline year-over-year.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$266.00K.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$331.00K.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$243.00K.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$694.00K, a 801.01% decline from fiscal 2023.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $99.00K, a 82.99% decline from fiscal 2022.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $582.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$10.36M 10-Q · filed 2026-08-04 | -$10.63M derived: sum of 3 quarters · filed 2026-08-04 | -$10.96M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$10.74M 10-Q · filed 2026-05-15 | -$11.01M derived: sum of 2 quarters · filed 2026-05-15 | -$11.34M derived: sum of 3 quarters · filed 2026-05-15 | -$11.43M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$597.00K derived: sum of 2 quarters · filed 2026-03-30 | -$681.00K derived: sum of 3 quarters · filed 2026-08-04 | -$243.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$415.00K derived: sum of 2 quarters · filed 2026-08-04 | $23.00K 10-Q · filed 2025-11-14 | -$519.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $354.00K 10-Q · filed 2026-08-04 | -$188.00K derived: sum of 3 quarters · filed 2026-08-04 | -$685.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $438.00K 10-Q · filed 2026-05-15 | -$104.00K derived: sum of 2 quarters · filed 2026-05-15 | -$601.00K derived: sum of 3 quarters · filed 2026-05-15 | -$972.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.04M derived: sum of 2 quarters · filed 2026-03-30 | -$1.41M derived: sum of 3 quarters · filed 2026-03-30 | -$694.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$868.00K derived: sum of 2 quarters · filed 2025-11-14 | -$152.00K 10-Q · filed 2025-11-14 | -$489.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $345.00K 10-Q · filed 2025-08-05 | $8.00K derived: sum of 3 quarters · filed 2025-08-05 | -$465.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $716.00K 10-Q · filed 2025-05-06 | $379.00K derived: sum of 2 quarters · filed 2025-05-06 | -$94.00K derived: sum of 3 quarters · filed 2025-05-06 | -$765.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$810.00K derived: sum of 2 quarters · filed 2025-03-28 | -$1.48M derived: sum of 3 quarters · filed 2025-03-28 | $99.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$473.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.14M derived: sum of 2 quarters · filed 2024-11-14 | $436.00K 10-Q · filed 2024-11-14 | -$22.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $909.00K 10-Q · filed 2024-08-06 | $451.00K derived: sum of 3 quarters · filed 2024-08-06 | -$1.45M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.58M 10-Q · filed 2024-05-09 | $1.12M derived: sum of 2 quarters · filed 2024-05-09 | -$774.00K derived: sum of 3 quarters · filed 2024-05-09 | $155.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$2.35M derived: sum of 2 quarters · filed 2024-02-29 | -$1.43M derived: sum of 3 quarters · filed 2024-02-29 | $582.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$967.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.04M 10-Q · filed 2023-11-07 | $388.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.94M 10-Q · filed 2023-08-03 | $2.28M derived: sum of 3 quarters · filed 2023-08-03 | $368.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $2.01M 10-Q · filed 2023-05-09 | $1.35M derived: sum of 2 quarters · filed 2023-05-09 | -$561.00K derived: sum of 3 quarters · filed 2023-05-09 | -$813.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$2.57M derived: sum of 2 quarters · filed 2023-03-29 | -$2.82M derived: sum of 3 quarters · filed 2023-03-29 | -$828.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.17M derived: sum of 2 quarters · filed 2022-11-08 | -$176.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.74M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $1.99M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.12M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |